HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Paul De La O Selected Research

Breast Neoplasms (Breast Cancer)

1/2021RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
12/2015Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Paul De La O Research Topics

Disease

3Neoplasms (Cancer)
01/2021 - 06/2009
2Breast Neoplasms (Breast Cancer)
01/2021 - 12/2015
1Neoplasm Metastasis (Metastasis)
12/2015
1Type 2 Diabetes Mellitus (MODY)
07/2012
1Chronic Pancreatitis
07/2012

Drug/Important Bio-Agent (IBA)

1Aromatase InhibitorsIBA
01/2021
1NVP-BKM120IBA
12/2015
1Phosphotransferases (Kinase)IBA
12/2015
1CateninsIBA
07/2012

Therapy/Procedure

3Therapeutics
01/2021 - 06/2009